Evaluating Osteogenic Differentiation of Osteoblastic Precursors Upon Intermittent Administration of PTH/IGFBP7.

Evaluating Osteogenic Differentiation of Osteoblastic Precursors Upon Intermittent Administration of PTH/IGFBP7.
复制标题

间歇性施用 PTH/IGFBP7 后评估成骨细胞前体的成骨分化

DOI:
10.3389/fphar.2022.839035
复制
发表时间:
2022
影响因子:
5.6
通讯作者:
Xue, Yuan
Xue, Yuan
中科院分区:
医学2区
文献类型:
--
作者:
Xia, Han;Tian, Yueyang;Lin, Yile;Huang, Qia;Xue, Yuan

文献摘要

参考文献

相似文献

甲状旁腺激素(PTH)1-34是第一个被批准用于治疗骨质疏松症的合成代谢药物。临床前证据显示PTH和骨肉瘤之间存在潜在关联。目前对PTH的骨形成和肿瘤形成机制的研究尚不完全清楚,关于胰岛素样生长因子结合蛋白7(IGFBP 7)在PTH合成代谢中的作用的研究报道较少。发现间歇性PTH给药增加间充质干细胞(MSC)和成骨细胞前体中IGFBP 7的表达。结果表明,当IGFBP 7敲低时,PTH的合成代谢作用被中断,而补充IGFBP 7蛋白可以增强PTH的成骨功效并调节信号通路。此外,在骨折的小鼠模型中,通过与PTH沿着施用IGFBP 7加速了骨愈合。由此可知,IGFBP 7是PTH的合成代谢作用所必需的,与单独给予PTH相比,联合给予PTH和IGFBP 7显示出更强的骨形成作用。
Parathyroid hormone (PTH) 1–34 is the first anabolic agent approved for the treatment of osteoporosis. Preclinical evidence shows a potential association between PTH and osteosarcoma. The mechanisms mediating the bone- and neoplasm-forming effects of PTH remain incompleted understood, few studies on the role of Insulin-like growth factor-binding protein 7 (IGFBP7) in mediating the anabolic effects of PTH has been reported. Intermittent PTH administration was found to increase the expression of IGFBP7 in mesenchymal stem cells (MSCs) and pre-osteoblasts. The results indicated that the anabolic effects of PTH were interrupted when knockdown of IGFBP7, while supplementation with IGFBP7 protein could enhance the bone-forming efficacy of PTH and regulate the signaling pathways. Moreover, bone healing was accelerated by the administration of IGFBP7 along with PTH in a mouse model of fracture. The obtained results proved that IGFBP7 was necessary for the anabolic effects of PTH, and combined administration of PTH and IGFBP7 showed stronger bone-forming effects relative to administration of PTH alone.
DOI: 10.1038/cddis.2014.268
发表时间: 2014-06-26
影响因子: 9
作者:
Verhagen HJ;de Leeuw DC;Roemer MG;Denkers F;Pouwels W;Rutten A;Celie PH;Ossenkoppele GJ;Schuurhuis GJ;Smit L
通讯作者: Smit L
DOI: 10.1158/0008-5472.can-16-2885
发表时间: 2017-08-01
期刊: Cancer research
影响因子: 11.2
作者:
Akiel M;Guo C;Li X;Rajasekaran D;Mendoza RG;Robertson CL;Jariwala N;Yuan F;Subler MA;Windle J;Garcia DK;Lai Z;Chen HH;Chen Y;Giashuddin S;Fisher PB;Wang XY;Sarkar D
通讯作者: Sarkar D
DOI: 10.1016/j.bone.2016.02.009
发表时间: 2016-05-01
期刊: BONE
影响因子: 4.1
作者:
Eriksen, Erik Fink;Brown, Jacques P.
通讯作者: Brown, Jacques P.
DOI: 10.1101/cshperspect.a031237
发表时间: 2018-08-01
影响因子: 5.4
作者:
Wein, Marc N.;Kronenberg, Henry M.
通讯作者: Kronenberg, Henry M.
维生素 K2 和 PTH 联合治疗可增强去势大鼠的骨形成并增加体外成骨细胞的分化
DOI: 10.1016/j.cbi.2019.01.012
发表时间: 2019-02-25
影响因子: 5.1
作者:
Weng, She-Ji;Yan, De-Yi;Yang, Lei
通讯作者: Yang, Lei